Company Filing History:
Years Active: 2006
Title: Michael J Elmore: Innovator in Botulinum Toxin Research
Introduction
Michael J Elmore is a notable inventor based in Basingstoke, GB. He has made significant contributions to the field of microbiology, particularly in the study of botulinum toxins. His innovative work has led to the development of a unique polypeptide that provides protection against type F botulinum toxin.
Latest Patents
Elmore holds a patent for a polypeptide free of toxin activity that offers protection against type F toxin. This patent, titled "Type F botulinum toxin and use thereof," describes a fusion protein that combines a fragment of a toxin molecule with a purification moiety. This fusion protein enables the purification of a fragment from solution and includes pharmaceutical compositions containing both the polypeptide and the fusion protein. He has 1 patent to his name.
Career Highlights
Michael J Elmore is associated with the Microbiological Research Authority, where he continues to advance research in microbiology and toxin studies. His work has implications for medical and pharmaceutical applications, particularly in developing treatments that mitigate the effects of botulinum toxins.
Collaborations
Elmore has collaborated with notable colleagues, including Margaret L Mauchline and Nigel P Minton. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation in the field.
Conclusion
Michael J Elmore's contributions to the study of botulinum toxins exemplify the impact of innovative research in microbiology. His patent and ongoing work at the Microbiological Research Authority highlight the importance of scientific advancements in developing protective measures against toxins.